Enanta Pharmaceuticals (ENTA) Minority Interest (2014 - 2015)
Enanta Pharmaceuticals posted quarterly Minority Interest of $164000.0 for Q4 2015, up 0.61% on a QoQ basis from $163000.0 in Q3 2015.
Enanta Pharmaceuticals (ENTA) has 2 years of Minority Interest data on file, last reported at $164000.0 in Q4 2015.
- For the quarter ending Q4 2015, Minority Interest changed N/A year-over-year to $164000.0; the trailing twelve-month figure through Dec 2015 stood at $164000.0 (changed N/A YoY), and the FY2015 full-year result was $163000.0, down 19.31% from the prior year.
- Minority Interest for Q4 2015 stood at $164000.0, up from $163000.0 in the prior quarter.
- Across five years, Minority Interest topped out at $202000.0 in Q3 2014 and bottomed at $163000.0 in Q3 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 164,000.00 |
| Sep 30, 2015 | 163,000.00 |
| Jun 30, 2015 | 185,000.00 |
| Sep 30, 2014 | 202,000.00 |